Reimagining Treatments for Complex Disease
NED Biosystems™, a Public Benefit Corporation, was founded to develop safe, efficacious, and comprehensive “systems” treatments for complex disease, beginning with the development of the patented NED-170 for treatment of cancer. A systems-based approach to treat disease comprehensively targets the behavior of the entire biological system instead of a single component.
NED-170 takes a systems approach that combines repurposed, oral agents well-documented in humans to affect critical cancer driving processes at doses that lack customary toxicity and side effects.
NED has deployed its systems methodology to develop NED-260 to be a universal antiviral treatment for a broad range of existing infectious diseases and those not yet known.
NED’s treatment platform strives to lessen the impact some of the deadliest diseases faced by patients today.